A researcher at the University of Missouri School of Medicine has received a $1.8 million grant from the National Institutes of Health to study asthma triggers. The asthma study will focus on ...

Among pediatric patients with hereditary angioedema, on-demand sebetralstat was generally safe and used within a median time of 30 minutes after attack onset, according to interim phase 3 trial ...

A new proposal in the New York State Assembly would require health insurance plans to fully cover asthma inhalers with no out ...

Clinicians met in Orlando for the 2025 ACAAI Annual Scientific Meeting to present the latest research on allergy, asthma, and ...

Women with breast cancer and preexisting atopic/allergic conditions faced a heightened risk for radiodermatitis up to 36 ...

The 2025 International Respiratory Immunology Summit, held on Nov 15, brought together leading experts to explore the latest ...

We congratulate Celeste Porsbjerg and colleagues for their Series paper1 addressing a key question in asthma care: the definition of the ideal candidate for biological therapy. Porsbjerg and ...

For anyone with asthma, keeping symptoms under control can sometimes feel like a constant struggle. Between seasonal weather ...

"Together, these highlight the fact that oral corticosteroids contribute to burden, even intermittently used," Oppenheimer ...

Nektar Therapeutics (NASDAQ:NKTR) shares climbed 3.6% on Monday after the biotech firm unveiled encouraging new data showing ...